Polly Moran, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 25 Newell Rd, D-28, Bristol, CT 06010 Phone: 860-584-4240 Fax: 860-585-5852 |
Judy K Morris, LNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 122 Maple St, Bristol, CT 06010 Phone: 860-583-1800 Fax: 860-584-4256 |
Miwako Ohta-agresta, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 25 Newell Rd, D28, Bristol, CT 06010 Phone: 860-584-4240 Fax: 860-585-5852 |
News Archive
Rapid improvement in the socio-economic conditions of the Gulf states has been followed by lifestyle changes now contributing to high rates of cardiovascular disease. Professor Hani Najm, President of the Saudi Heart Association whose annual conference begins 21 February 2011, describes risk factor prevalence rates as "extremely high", particularly in the cities of Saudi Arabia.
Abraxis BioScience, Inc., a fully integrated biotechnology company, today announced that the Office of Orphan Products Development of the Food and Drug Administration (FDA) has granted orphan drug designation to the chemotherapy agent ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) for the treatment of pancreatic cancer as well as stage IIB-IV melanoma.
An Albuquerque startup company has licensed a Sandia National Laboratories technology that offers a way to make molybdenum-99, a key radioactive isotope needed for diagnostic imaging in nuclear medicine, in the United States.
A recent study based at a hospital in Buenos Aires, Argentina, found that convalescent plasma therapy for patients with severe COVID-19, and COVID-19-related pneumonia, was largely ineffective.
› Verified 4 days ago